Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous BP Monitoring with Biobeat and Aktiia vs ABPM
NCT05692869Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2023
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: The Mean Change in Systolic Blood Pressure (SBP) Using Chest Patch Device at 48 hours. Started Jan 2023; status: completed.
Beyond the preview
Go deeper on NCT05692869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692869.